Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Eli Lilly: A Long-Term Growth Stock
Eli Lilly: A Long-Term Growth Stock
Eli Lilly: A Long-Term Growth Stock
Submitted by
admin
on July 2, 2012 - 10:42am
Source:
Seeking Alpha
News Tags:
Eli Lilly
diabetes
Bristol-Myers Squibb
Incyte
Merck
Sanofi
Novo Nordisk
Headline:
Eli Lilly: A Long-Term Growth Stock
Do Not Allow Advertisers to Use My Personal information
